Streetbeat News

Partnerships

GAMB

Gambling.com Group has entered into a partnership with Independent Digital News and Media Limited. The partnership will combine The Independent's 20.8M+ unique visitors with Gambling.com Group's U.K. leadership position and leading player acquisition services for the regulated global online gambling industry.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 12:44 pm

ITI

Iteris, Inc. (NASDAQ:ITI) has been awarded a three-year, $1.3 million SaaS contract by the Los Angeles County Metropolitan Transportation Authority (LA Metro) for the continued use of ClearGuide, a technology that provides transportation analytics to support mobility and safety applications. The contract demonstrates LA Metro's confidence in ClearGuide and Iteris' services.

Portfolio Pulse from Happy Mohamed

July 11, 2023 | 12:44 pm

ADEA

Adeia Inc. (NASDAQ:ADEA) has renewed its agreement with Enseo, LLC, a technology services provider for the hospitality industry, to license Adeia's media intellectual property portfolio. Enseo provides technology solutions that improve the in-room digital entertainment experience of hotel and resort guests. The agreement validates Adeia's market-leading technology as an enabler of digital entertainment experiences in the hospitality industry.

Portfolio Pulse from Happy Mohamed

July 11, 2023 | 12:43 pm

DFLI

Dragonfly Energy has announced a partnership with NuCamp, a teardrop manufacturer, to provide full lithium power systems. This news has led to an increase in Dragonfly Energy's share price.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 12:42 pm

BLIN

Bridgeline Digital has announced a partnership with RafterOne, a Salesforce agency partner of Interpublic Group. This partnership is expected to expand Bridgeline's customer base and enhance its product offerings.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 12:38 pm

BTTX

CING

DFLI

Cingulate Therapeutics (CING) announced positive results from Phase 3 trial of CTx-1301 for ADHD, causing its stock to surge by 81.5%. Dragonfly Energy (DFLI) partnered with the world's largest teardrop manufacturer to provide full lithium power systems, leading to a 45.8% increase in its stock. Better Therapeutics (BTTX) saw a 24.5% rise in its shares after the FDA approved its AspyreRx prescription-only digital therapeutic treatment for type 2 diabetes.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 12:38 pm

LICY

Li-Cycle Holdings Corp (NYSE:LICY) has signed a memorandum of understanding (MOU) with EVE Energy Co Ltd to explore lithium-ion battery recycling solutions for EVE battery materials. The MOU includes recycling collaborations on battery manufacturing scrap generated at EVE's planned lithium-ion battery cell manufacturing facilities in Malaysia and Hungary. The partnership will support EVE’s sustainability goals with a closed-loop supply solution.

Portfolio Pulse from Shivani Kumaresan

July 11, 2023 | 12:33 pm

DCFC

Tritium DCFC Limited (NASDAQ:DCFC) has been selected to provide all fast chargers for the first phase of Hawai'i's National Electric Vehicle Infrastructure (NEVI) Formula Program. This makes Tritium the first manufacturer to secure a fast charger order through NEVI program funding. The Federal Highway Administration approved Hawai'i's Electric Vehicle Infrastructure Deployment Plan in September 2022, granting the state access to $2.6 million of NEVI funding in FY2022. The state is expected to receive a total of $17.6 million in funding throughout the duration of the NEVI Formula Program.

Portfolio Pulse from Happy Mohamed

July 11, 2023 | 12:31 pm

AMZN

ASUR

Asure Software (NASDAQ:ASUR) has partnered with Amazon Web Services (AWS) to join its Application Modernization Lab. The collaboration will allow Asure to leverage advancements in cloud optimization and artificial intelligence for its Human Capital Management (HCM) software solutions. The partnership aims to enhance performance, scalability, and security of Asure's offerings, and accelerate its modernization efforts.

Portfolio Pulse from Happy Mohamed

July 11, 2023 | 12:30 pm

PPBT

Purple Biotech Ltd. (NASDAQ/TASE: PPBT) has announced the completion of its Phase 1 dose escalation study of CM24, a first-in-class anti-CEACAM1 monoclonal antibody addressing multiple tumor types. The study involved 11 pancreatic ductal adenocarcinoma (PDAC) patients and the results showed that the investigational immunotherapy combination was well tolerated across all dose levels with no recorded Drug Limiting Toxicities. The company is now conducting a Phase 2 randomized study of CM24 in collaboration with Bristol Myers Squibb.

Portfolio Pulse from Happy Mohamed

July 11, 2023 | 12:16 pm